Diabetes and Endocrinology
Home Diabetes and Endocrinology
December 2017 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for December 2017. This roundup includes...
Length of Surgery Predicts Bleeding After Vitrectomy
Prolonged surgery time predicts 12- to 52-week post-op bleeding risk in patients with diabetic retinopathy
Increase Seen in Gabapentinoid Use From 2002 to 2015
More than three-fold increase in percentage of adults using gabapentin and/or pregabalin
Intensive Lifestyle Intervention Linked to Cerebral Blood Flow
In obese, overweight adults with T2DM, long-term weight loss intervention tied to greater blood flow
Risk of ESRD in T1DM Patients Has Fallen Markedly in Finland
Relative risk of end-stage renal disease was 0.13 in those diagnosed in 1995-2011 versus 1965-1979
Calcium, Vitamin D Don’t Seem to Reduce Fracture Risk in Seniors
No reduction in incidence of fractures among community-dwelling older adults taking supplements
Text Message Interventions May Help With Weight Management
Interventions classified as effective were more likely to last longer than 12 weeks
Plasma Volume Changes May Mediate Effects of Empagliflozin
Findings suggest reduced CV mortality risk mediated by effects on markers of plasma volume
Pioglitazone Associated With Lower Blood Leptin in Diabetes
In T2DM, leptin levels are lower with pioglitazone than placebo but not oral antidiabetic drugs
CDC: 2015 to 2016 Saw Drop in Life Expectancy in United States
Increase in rate of age-adjusted drug overdose deaths observed during same time period
